Tuberculosis News and Research

Latest Tuberculosis News and Research

New compound circumvents drug-efflux pumps associated with Gram-positive bacteria

It's no wonder that medicine's effort to combat bacterial infections is often described as an arms race. When new drugs are developed to combat infections, the bacterial target invariably comes up with a deterrent.

29 Nov 2011

Funds for AIDS, tuberculosis and malaria dry up

A global fund organization against three killer diseases says it has run out of money to pay for new grant programs for the next two years. An official with the Global Fund to Fight AIDS, Tuberculosis and Malaria said Thursday that it has been forced to cease giving new grants until 2014 because of global economic woes brought on by debt crises in the U.S. and Europe.

27 Nov 2011

Oral antibiotics might treat Buruli ulcer

It might be possible to treat Buruli ulcer, a crippling and deforming disease, with only oral medicines, which would make treatment easier. And even the current treatment can in many cases be given in an outpatient regimen.

23 Nov 2011

Potential cuts to global health spending threaten vision of 'AIDS-free generation'

The vision of an "AIDS-free generation" presented in a speech earlier this month by Secretary of State Hillary Rodham Clinton "is under threat in Congress," as "the House and the Senate are discussing significant cuts to the 2012 Obama administration request for global health funding," Jeanie Yoon, a physician with Doctors Without Borders/Medecins Sans Frontieres (MSF), writes in a Baltimore Sun opinion piece.

22 Nov 2011

Three 'critical issues' for Global Fund to consider to ensure 'further success'

While the recent report from a High-Level Independent Review Panel of the Global Fund to Fight AIDS, Tuberculosis and Malaria, "and the corresponding decisions of the Board, mark an important step towards the necessary improvements the Global Fund must make to fulfill its vital mandate in the coming decade and beyond," "the report does not provide direction or solutions on certain critical issues that will define the further success and impact of the Global Fund," Richard Feachem, founding executive director of the Global Fund, writes in a Lancet commentary.

19 Nov 2011

Sony Corporation, Global Fund enter into partnership to implement behavior change projects

"Sony Corporation and the Global Fund to Fight AIDS, Tuberculosis and Malaria have entered into a partnership for the implementation of behavior change projects, in which Sony provides state of the art equipment and movies and the Global Fund ensures it gets to agencies best able to reach communities most in need," a Global Fund press release states, noting, "This partnership is the first pilot case that combines pro bono and in-kind contribution."

19 Nov 2011

Aid targeting high mortality diseases 'lays the groundwork' for improving primary health care services

"In recent years, initiatives such as the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis, and Malaria have helped rein in some of the biggest scourges," Paul Farmer, co-founder of Partners in Health and chair of the Department of Global Health and Social Medicine at Harvard Medical School, writes in a Washington Post opinion piece.

19 Nov 2011

Efforts to end AIDS could also reduce TB burden with proper funding

In response to Michael Gerson's November 11 column in which he said the end of AIDS is possible because of combination prevention and treatment innovations, David Bryden, the Stop TB advocacy officer at RESULTS, writes in a Washington Post letter to the editor, "Another benefit of [HIV] treatment is that it sharply reduces deaths from tuberculosis [TB], which is the primary killer of people living with HIV/AIDS."

18 Nov 2011

Report by aid watchdog group finds many international donors lack transparency

IRIN examines the results of a report by the aid watchdog group Publish What You Fund that examines "whether donors publish information about their budgets, their allocation and procurement policies, or audit reports on their own performance" and "finds that most international aid donors are still not open enough about their aid programs, and some offer no information at all."

18 Nov 2011

South African public health experts urge countries to use TRIPS to produce generic drugs, IPS reports

South African public health experts from Medecins San Frontieres (MSF) South Africa and the Treatment Action Campaign (TAC) "are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries," Inter Press Service reports.

18 Nov 2011

Eli Lilly provides $4M in additional funding to IDRI for new TB therapies

Eli Lilly and Company today announced that it is providing more than $4 million in additional funding to the Infectious Disease Research Institute. The funding will allow IDRI to continue its early phase drug discovery efforts focused on identifying new and better therapies in the fight against tuberculosis, including multidrug-resistant strains known as MDR-TB.

17 Nov 2011

New collaboration enables information sharing to aid in development of TB drug candidates

In this post in the Global Health Technologies Coalition's "Breakthroughs" blog, Heather Ignatius, senior policy manager for the TB Alliance, writes that while "the most recent WHO TB Control report noted that rates of tuberculosis (TB) declined this past year for the first time in decades, ... TB remains one of the most devastating global health crises today, with ripple effects that extend beyond health to cripple prosperity and development of regions overwhelmed by the disease."

17 Nov 2011

Non-therapeutic antibiotic usage in food animals creates resistance genes, promotes antibiotic resistance

In a review study, researchers from Tufts University School of Medicine zero in on the controversial, non-therapeutic use of antibiotics in food animals and fish farming as a cause of antibiotic resistance.

16 Nov 2011

Streamlining clinical trials review process to speed up delivery of drugs to those in need

In this Atlantic opinion piece, Amanda Glassman, director of Global Health Policy at the Center for Global Development (CGD), reports on how lengthy, inefficient review processes for drug and vaccine candidates waiting in the pipeline for late stages of clinical development is keeping promising new medicines, vaccines, and diagnostic techniques from reaching millions in need.

16 Nov 2011

NIAID's ACTG and TB Alliance partner to complete moxifloxacin Phase III trial

The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases' (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.

16 Nov 2011

Clinton's speech prioritizing creation of 'Aids-free generation' may shape future of U.S. global health strategy, analysts say

U.S. Secretary of State Hillary Clinton's November 8 speech at the NIH, in which she called for the creation of an "AIDS-free generation" through the use of combination prevention strategies, "could be more than just political lip-service: it may also shape the next several years of U.S. global health programming and funding, analysts say," PlusNews reports.

15 Nov 2011

VOA News examines Foundation's efforts to treat MDR-TB patients in North Korea

VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "conditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes.

15 Nov 2011

Mtb produces specific protein that allows it to defuse and bypass body's security system

Tuberculosis, which kills over 2 million people each year, is caused primarily by infectious bacteria known as Mycobacterium tuberculosis - or Mtb. Mtb targets human immune cells as part of its strategy to avoid detection, effectively neutralizing the body's immune response.

15 Nov 2011

Researchers in Philippines develop machine to quickly detect drug-resistant TB

In this post in the Global Post's "Global Pulse" blog, journalist John Donnelly reports on how a machine developed by researchers at the TB Laboratory at the Lung Center of the Philippines "that can detect multi-drug resistant tuberculosis (MDR-TB) in record time may revolutionize TB treatment."

15 Nov 2011

Cambodia set to distribute more than 2.5M mosquito nets by end of year

"Millions of Cambodians are set to receive insecticide-treated mosquito nets as part of a government-led effort to mitigate the risk of malaria and dengue fever," IRIN reports.

14 Nov 2011

Tuberculosis News and Research

Latest Tuberculosis News and Research

New compound circumvents drug-efflux pumps associated with Gram-positive bacteria

Funds for AIDS, tuberculosis and malaria dry up

Oral antibiotics might treat Buruli ulcer

Potential cuts to global health spending threaten vision of 'AIDS-free generation'

Three 'critical issues' for Global Fund to consider to ensure 'further success'

Sony Corporation, Global Fund enter into partnership to implement behavior change projects

Aid targeting high mortality diseases 'lays the groundwork' for improving primary health care services

Efforts to end AIDS could also reduce TB burden with proper funding

Report by aid watchdog group finds many international donors lack transparency

South African public health experts urge countries to use TRIPS to produce generic drugs, IPS reports

Eli Lilly provides $4M in additional funding to IDRI for new TB therapies

New collaboration enables information sharing to aid in development of TB drug candidates

Non-therapeutic antibiotic usage in food animals creates resistance genes, promotes antibiotic resistance

Streamlining clinical trials review process to speed up delivery of drugs to those in need

NIAID's ACTG and TB Alliance partner to complete moxifloxacin Phase III trial

Clinton's speech prioritizing creation of 'Aids-free generation' may shape future of U.S. global health strategy, analysts say

VOA News examines Foundation's efforts to treat MDR-TB patients in North Korea

Mtb produces specific protein that allows it to defuse and bypass body's security system

Researchers in Philippines develop machine to quickly detect drug-resistant TB

Cambodia set to distribute more than 2.5M mosquito nets by end of year

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in